Immediate Impact
1 from Science/Nature 65 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Darrel R. Borger being referenced
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
2015
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Darrel R. Borger | 225 | 9 | 119 | 152 | 139 | 7 | 365 | |
| Shu Abe | 117 | 62 | 56 | 116 | 162 | 8 | 402 | |
| P Autzen | 213 | 17 | 111 | 249 | 87 | 9 | 395 | |
| Brigitte Poirot | 160 | 29 | 89 | 167 | 120 | 12 | 363 | |
| Josephine J. Marshalleck | 118 | 45 | 97 | 116 | 104 | 10 | 317 | |
| Jinchang Sun | 106 | 32 | 78 | 173 | 70 | 8 | 327 | |
| Wenhsiang Wen | 219 | 12 | 109 | 210 | 62 | 8 | 369 | |
| Mara Merli | 127 | 9 | 225 | 185 | 89 | 8 | 375 | |
| Ghislaine Sierankowski | 214 | 25 | 168 | 123 | 87 | 7 | 375 | |
| Sabeeha Muneer | 143 | 26 | 67 | 222 | 60 | 5 | 374 | |
| Vice Mandic | 112 | 19 | 27 | 266 | 82 | 9 | 394 |
All Works
Loading papers...